Korro Bio, Inc. Capital Expenditures
Korro Bio, Inc. (KRRO) reported Capital Expenditures of $58.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- Korro Bio, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $37.00K, a 73.57% decline year-over-year.
- Korro Bio, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $21.00K, a 82.35% decline year-over-year.
- Korro Bio, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $84.00K, a 94.21% decline year-over-year.
- Korro Bio, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $175.00K, a 96.41% decline year-over-year.
- Korro Bio, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $518.00K, a 97.11% decline from fiscal 2024.
- Korro Bio, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $17.90M, a 128.46% increase from fiscal 2023.
- Korro Bio, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $7.84M, a 52.57% increase from fiscal 2022.
- Korro Bio, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $5.14M, a 76.25% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $58.00K 10-Q · filed 2026-08-06 | $142.00K derived: sum of 3 quarters · filed 2026-08-06 | $317.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $21.00K 10-Q · filed 2026-05-07 | $105.00K derived: sum of 2 quarters · filed 2026-05-07 | $280.00K derived: sum of 3 quarters · filed 2026-05-07 | $420.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $84.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $259.00K derived: sum of 2 quarters · filed 2026-03-12 | $399.00K derived: sum of 3 quarters · filed 2026-08-06 | $518.00K 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | $175.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $315.00K derived: sum of 2 quarters · filed 2026-08-06 | $434.00K 10-Q · filed 2025-11-12 | $1.89M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $140.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $259.00K 10-Q · filed 2026-08-06 | $1.71M derived: sum of 3 quarters · filed 2026-08-06 | $6.59M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $119.00K 10-Q · filed 2026-05-07 | $1.57M derived: sum of 2 quarters · filed 2026-05-07 | $6.45M derived: sum of 3 quarters · filed 2026-05-07 | $12.41M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $6.33M derived: sum of 2 quarters · filed 2026-03-12 | $12.29M derived: sum of 3 quarters · filed 2026-03-12 | $17.90M 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | $4.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $10.84M derived: sum of 2 quarters · filed 2025-11-12 | $16.45M 10-Q · filed 2025-11-12 | $18.11M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $5.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $11.57M 10-Q · filed 2025-08-12 | $13.23M derived: sum of 3 quarters · filed 2025-08-12 | $13.47M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $5.61M 10-Q · filed 2025-05-07 | $7.27M derived: sum of 2 quarters · filed 2025-05-07 | $7.51M derived: sum of 3 quarters · filed 2025-05-07 | $11.93M derived: sum of 4 quarters · filed 2025-05-07 | ||||
| 2023-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $1.90M derived: sum of 2 quarters · filed 2025-03-18 | $6.32M derived: sum of 3 quarters · filed 2025-03-18 | $7.84M 10-K · filed 2025-03-18 | ||||
| 2023-09-30 | $246.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $4.67M derived: sum of 2 quarters · filed 2024-11-12 | $6.18M 10-Q · filed 2024-11-12 | $100.00K 10-Q · filed 2023-11-02 | $11.32M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $4.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $5.93M 10-Q · filed 2024-08-13 | $100.00K 10-Q · filed 2023-08-10 | $11.07M derived: sum of 3 quarters · filed 2024-08-13 | $11.05M derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | $1.51M 10-Q · filed 2024-05-14 | $100.00K 10-Q · filed 2023-05-12 | $6.65M derived: sum of 2 quarters · filed 2024-05-14 | $6.63M derived: sum of 3 quarters · filed 2024-05-14 | $6.64M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $5.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $5.12M derived: sum of 2 quarters · filed 2024-03-26 | $5.12M derived: sum of 3 quarters · filed 2024-03-26 | $5.14M 10-K · filed 2024-03-26 | $0.00 10-K · filed 2023-03-10 | |||
| 2022-09-30 | -$16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$12.00K derived: sum of 2 quarters · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | $61.00K derived: sum of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $16.00K 10-Q · filed 2023-08-10 | $77.00K derived: sum of 3 quarters · filed 2023-08-10 | $388.00K derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $12.00K 10-Q · filed 2023-05-12 | $73.00K derived: sum of 2 quarters · filed 2023-05-12 | $384.00K derived: sum of 3 quarters · filed 2023-05-12 | $2.38M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $372.00K derived: sum of 2 quarters · filed 2023-03-10 | $2.37M derived: sum of 3 quarters · filed 2023-03-10 | $2.91M 10-K · filed 2023-03-10 | ||||
| 2021-09-30 | $311.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.31M derived: sum of 2 quarters · filed 2022-11-08 | $2.85M 10-Q · filed 2022-11-08 | $7.27M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $2.54M 10-Q · filed 2022-08-09 | $6.96M derived: sum of 3 quarters · filed 2022-08-09 | $7.96M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | $543.00K 10-Q · filed 2022-05-04 | $4.96M derived: sum of 2 quarters · filed 2022-05-04 | $5.96M derived: sum of 3 quarters · filed 2022-05-04 | $6.87M derived: sum of 4 quarters · filed 2022-05-04 | ||||
| 2020-12-31 | $4.42M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $5.42M derived: sum of 2 quarters · filed 2022-03-15 | $6.33M derived: sum of 3 quarters · filed 2022-03-15 | $6.67M 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.91M derived: sum of 2 quarters · filed 2021-11-15 | $2.25M 10-Q · filed 2021-11-15 | $2.67M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $909.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $1.25M 10-Q · filed 2021-08-12 | $1.67M derived: sum of 3 quarters · filed 2021-08-12 | $1.83M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $343.00K 10-Q · filed 2021-05-13 | $764.00K derived: sum of 2 quarters · filed 2021-05-13 | $919.00K derived: sum of 3 quarters · filed 2021-05-13 | $948.00K derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $421.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $576.00K derived: sum of 2 quarters · filed 2021-03-29 | $605.00K derived: sum of 3 quarters · filed 2021-03-29 | $1.06M 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | $155.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $184.00K derived: sum of 2 quarters · filed 2020-11-16 | $643.00K 10-Q · filed 2020-11-16 | $882.00K derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | $29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $488.00K 10-Q · filed 2020-08-12 | $727.00K derived: sum of 3 quarters · filed 2020-08-12 | |||||
| 2019-03-31 | $459.00K 10-Q · filed 2020-05-14 | $698.00K derived: sum of 2 quarters · filed 2020-05-14 | ||||||
| 2018-12-31 | $239.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $436.00K 10-K · filed 2020-03-26 | ||||||
| 2018-09-30 | $197.00K 10-Q · filed 2019-11-18 | |||||||
| 2017-12-31 | $1.86M 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |